CITI/CALL/PFIZER INC/24/0.1/19.06.25 Stock

DE000KJ2VCE6

Market Closed - Boerse Frankfurt Warrants 01:40:15 2024-06-26 pm EDT
0.44 ^EUR	-8.33%

1 month	-18.52%
3 months	-8.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart PFIZER, INC.

Chart CITI/CALL/PFIZER INC/24/0.1/19.06.25

Latest news about PFIZER, INC.

Pfizer Keeps Q3 Dividend at $0.42 a Share, Payable Sept. 3 to Holders of Record July 26	04:42pm	MT
Pfizer Declares Third-Quarter 2024 Dividend	04:31pm	BU
Vaccine panel more strongly endorses RSV shots for oldest Americans	04:25pm	AQ
Moderna Shares Fall as RSV Shot Efficacy Lags Behind Rivals' Vaccines, CDC Data Shows	03:49pm	MT

More news

Quotes 5-day view

Date	Price	Change
24-06-26	0.44	-8.33%
24-06-25	0.48	+2.13%
24-06-24	0.47	+4.44%
24-06-21	0.45	-4.26%
24-06-20	0.47	+6.82%

Real-time Boerse Frankfurt Warrants

Last update June 26, 2024 at 01:40 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	PFIZER, INC.
Issuer	Citi
WKN	KJ2VCE
ISIN	DE000KJ2VCE6
Date issued	2023-12-18
Strike	24 $
Maturity	2025-06-19 (358 Days)
Parity	10 : 1
Emission price	0.41 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.67 €
Lowest since issue	0.33 €

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).

Sector

More about the company